Cristina Teixido

Cristina Teixido

UNVERIFIED PROFILE

Are you Cristina Teixido?   Register this Author

Register author
Cristina Teixido

Cristina Teixido

Publications by authors named "Cristina Teixido"

Are you Cristina Teixido?   Register this Author

44Publications

1899Reads

24Profile Views

Clinical Benefit From BRAF/MEK Inhibition in a Double Non-V600E BRAF Mutant Lung Adenocarcinoma: A Case Report.

Clin Lung Cancer 2019 May 4;20(3):e219-e223. Epub 2019 Mar 4.

Department of Medical Oncology, Hospital Clínic, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.02.022DOI Listing
May 2019

RNA Analysis as a Tool to Determine Clinically Relevant Gene Fusions and Splice Variants.

Arch Pathol Lab Med 2018 Apr;142(4):474-479

From the Department of Pathology, Hospital Clínic, Barcelona, Spain (Dr Teixidó); Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (Dr Teixidó); Pangaea Oncology, Oncology Laboratory, Dexeus University Hospital - Quirónsalud Group, Barcelona, Spain (Ms Giménez-Capitán and Drs Molina-Vila, Peg, Karachaliou, Castellví, and Rosell); the Department of Pathology, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain (Drs Peg and Castellví); Morphological Sciences Department, Universitat Autònoma de Barcelona, Barcelona, Spain (Drs Peg and Castellví); Institute of Oncology Rosell (IOR), University Hospital Sagrat Cor and Quirónsalud Group, Barcelona, Spain (Drs Karachaliou and Rosell); the Department of Medical Oncology, Canarias University Hospital, San Cristóbal de La Laguna, Tenerife, Spain (Dr Rodríguez-Capote); and Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Spain (Dr Rosell).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0134-RADOI Listing
April 2018

PD-L1 expression testing in non-small cell lung cancer.

Ther Adv Med Oncol 2018 11;10:1758835918763493. Epub 2018 Apr 11.

Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835918763493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898658PMC
April 2018

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.

Ther Adv Med Oncol 2018 18;10:1758834017749748. Epub 2018 Jan 18.

Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain Institut d'Investigació en Ciències Germans Trias i Pujol, Badalona, Spain Instituto Oncológico Dr Rosell (IOR), Quirón-Dexeus University Institute, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834017749748DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784541PMC
January 2018

Neutrophils dominate the immune landscape of non-small cell lung cancer.

J Thorac Dis 2017 May;9(5):E468-E469

Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2017.04.55DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465158PMC
May 2017

Liquid Biopsy in Non-Small Cell Lung Cancer.

Front Med (Lausanne) 2016 23;3:69. Epub 2016 Dec 23.

Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona, Spain; Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmed.2016.00069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179978PMC
December 2016

mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients.

Transl Lung Cancer Res 2016 Oct;5(5):511-516

Pangaea Biotech, Laboratory of Oncology, Quirón Dexeus University Hospital, 08028 Barcelona, Spain;; Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, 08028 Barcelona, Spain;; Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Crta de Canyet s/n, 08016 Badalona, Spain;; Autonomous University of Barcelona (UAB), Campus Can Ruti, Crta de Canyet s/n, 08016 Badalona, Spain;; Molecular Oncology Research (MORe) Foundation, 08028 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2016.10.14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099515PMC
October 2016

Usefulness of circulating free DNA for monitoring epidermal growth factor receptor mutations in advanced non-small cell lung cancer patients: a case report.

Transl Lung Cancer Res 2016 Oct;5(5):532-537

Pangaea Biotech, Medical Oncology Laboratory, Dexeus University Hospital, Quirónsalud Group, Barcelona, Spain;; Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Dexeus University Hospital-Quirónsalud Group, Barcelona, Spain;; Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Germans Triasi Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Badalona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2016.10.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099508PMC
October 2016

MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer.

Gastric Cancer 2016 Jul 24;19(3):778-88. Epub 2015 Sep 24.

The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-015-0545-5DOI Listing
July 2016

Examining hippocampal function in schizophrenia using a virtual reality spatial navigation task.

Schizophr Res 2016 Apr 28;172(1-3):86-93. Epub 2016 Feb 28.

FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2016.02.033DOI Listing
April 2016

Immunotherapy meets targeted therapy: will this team end the war against cancer?

Transl Lung Cancer Res 2015 Dec;4(6):752-5

1 Rosell Oncology Institute, Quirón-Dexeus University Hospital, Barcelona, Spain ; 2 Pangaea Biotech, Barcelona, Spain ; 3 Institut Quimic de Sarriá, Barcelona, Spain ; 4 Institut Catalá d'Oncologia, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2015.12.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700229PMC
December 2015

Melanoma: oncogenic drivers and the immune system.

Ann Transl Med 2015 Oct;3(18):265

1 Instituto Oncológico Dr Rosell, Quiron-Dexeus University Hospital, Barcelona, Spain ; 2 Department of Medical Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy ; 3 Pangaea Biotech, Quirón Dexeus University Institute, Barcelona, Spain ; 4 Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain ; 5 Medical Oncology Unit, Human Pathology Department, University of Messina, Messina 98122, Italy ; 6 Instituto Oncológico de Córdoba, Córdoba, Argentina ; 7 Molecular Oncology Research (MORe) Foundation, Barcelona, Spain ; 8 Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2305-5839.2015.08.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630557PMC
October 2015

Other targeted drugs in melanoma.

Ann Transl Med 2015 Oct;3(18):266

1 Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona, Spain ; 2 Vall D'Hebron Institute of Oncology and Universitat Autonoma de Barcelona, Barcelona, Spain ; 3 Immunology Department, CNICV, Madrid, Spain ; 4 Medical Oncology Unit, Human Pathology Department, University of Messina, Messina, Italy ; 5 Department of Medical Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy ; 6 Pangaea Biotech S.L, Barcelona, Spain ; 7 Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Badalona, Barcelona, Spain ; 8 Fundación Molecular Oncology Research, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2305-5839.2015.08.12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630555PMC
October 2015

Neoadjuvant Chemoradiotherapy Treatment for a Classic Biphasic Pulmonary Blastoma with High PD-L1 Expression.

Anticancer Res 2015 Sep;35(9):4871-5

Cancer Biology and Precision Medicine Program, Germans Trias i Pujol University Hospital, Badalona, Spain Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona, Spain Molecular Oncology Research Foundation (MORe), Barcelona, Spain

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/35/9/4871.full.pdf
Web Search
September 2015

Advances in immunotherapy for treatment of lung cancer.

Cancer Biol Med 2015 Sep;12(3):209-22

1 Albert Einstein Medical Center, Philadelphia 19141, USA ; 2 Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona 08028, Spain ; 3 Medical Oncology Unit, Human Pathology Department, University of Messina, Messina 98100, Italy ; 4 Pangaea Biotech S.L, Barcelona 08028, Spain ; 5 Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Badalona, Barcelona 08916, Spain ; 6 Fundación Molecular Oncology Research, Barcelona 08028, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607819PMC
September 2015

Erratum to Assays for predicting and monitoring responses to lung cancer immunotherapy.

Cancer Biol Med 2015 Sep;12(3):259

1 Pangaea Biotech, Quirón Dexeus University Hospital, Barcelona 08028, Spain ; 2 Dr. Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona 08028, Spain ; 3 Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona 08916, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607823PMC
September 2015

Predictive factors for immunotherapy in melanoma.

Ann Transl Med 2015 Sep;3(15):208

1 Pangaea Biotech, 2 Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, 08028 Barcelona, Spain ; 3 Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, 08916 Badalona, Spain ; 4 Molecular Oncology Research Foundation (MORe), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2305-5839.2015.05.07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583591PMC
September 2015

Targeting PD-1/PD-L1 in lung cancer: current perspectives.

Lung Cancer (Auckl) 2015 31;6:55-70. Epub 2015 Jul 31.

Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital, Barcelona, Spain; Pangaea Biotech SL, Barcelona, Spain; Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Badalona, Barcelona, Spain; Fundación Molecular Oncology Research, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/LCTT.S55176DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217517PMC
July 2015

Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints.

Cancer Biol Med 2015 Jun;12(2):79-86

1 Instituto Oncológico Dr Rosell, Quiron Dexeus University Hospital, Barcelona 08028, Spain ; 2 Pangaea Biotech, Barcelona 08028, Spain ; 3 Medical Oncology Unit, Human Pathology Department, University of Messina, Messina 98122, Italy ; 4 Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona 08916, Spain ; 5 Molecular Oncology Research (MORe) Foundation, Barcelona 08028, Spain ; 6 Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti 08916, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493378PMC
June 2015

Assays for predicting and monitoring responses to lung cancer immunotherapy.

Cancer Biol Med 2015 Jun;12(2):87-95

1 Pangaea Biotech, Quirón Dexeus University Hospital, Barcelona 08028, Spain ; 2 Dr. Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona 08028, Spain ; 3 Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona 08916, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493376PMC
June 2015

TAZ is highly expressed in gastric signet ring cell carcinoma.

Biomed Res Int 2014 24;2014:393064. Epub 2014 Feb 24.

The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing 210008, China.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/bmri/2014/393064/
Publisher Site
http://dx.doi.org/10.1155/2014/393064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953576PMC
January 2015

A critical question for cancer therapy: what new targets exist?

Transl Lung Cancer Res 2014 Dec;3(6):384-8

1 Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain ; 2 Molecular Oncology Research (MORe) Foundation, Sabino Arana 5-19, Barcelona, Spain ; 3 Instituto Oncológico Dr Rosell, Barcelona, Spain ; 4 Pangaea Biotech S.L, Sabino Arana 5-19, Barcelona, Spain ; 5 Institut Quìmic de Sarrià, Via Augusta 390, Barcelona, Spain ; 6 Fundació Institut de Investigació Germans Trias i Pujol, Badalona, Spain ; 7 Instituto Oncológico Nacional, Calle Gorgas, Ancon, Panamá

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2014.08.10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367674PMC
December 2014

ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation.

Transl Lung Cancer Res 2014 Jun;3(3):122-30

1 Dr Rosell Oncology Institute, 2 Pangaea Biotech S.L, Quirón Dexeus University Hospital, Barcelona, Spain ; 3 Pivotal CRO, Madrid, Spain ; 4 Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain ; 5 Hospital General de Alicante, Alicante, Spain ; 6 CHU Limoges, Limoges, France ; 7 European Institute of Oncology (IEO), Milan, Italy ; 8 Molecular Oncology Research (MORe) Foundation, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2014.03.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367691PMC
June 2014

Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements.

Transl Lung Cancer Res 2014 Apr;3(2):70-4

1 Pangaea Biotech, Quirón Dexeus University Institute, 08028 Barcelona, Spain, 2 Dr Rosell Oncology Institute, Quirón Dexeus University Institute, 08028 Barcelona, Spain ; 3 Catalan Institute of Oncology, Hospital Germans Trias i Pujol, 08916 Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2014.02.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367661PMC
April 2014

Impact of the new EGF receptor and ALK testing guideline on personalized lung cancer medicine.

Per Med 2013 Jul;10(5):415-417

Breakthrough Cancer Research Unit, Pangaea Biotech, Quiron Dexeus University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pme.13.39DOI Listing
July 2013

RSK4 inhibition results in bypass of stress-induced and oncogene-induced senescence.

Carcinogenesis 2011 Apr 14;32(4):470-6. Epub 2011 Jan 14.

Department of Pathology, Vall d'Hebron University Hospital, and Department of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgr003DOI Listing
April 2011